Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. Jun 16, 2023; 15(6): 480-490
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.480
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.480
Risk factor | Odds ratio | P value |
Gender | ||
Female | Reference | |
Male | 1.28 | 0.269 |
Race and ethnicity | ||
White | Reference | |
Black | 1.50 | 0.080 |
Other1 | 2.55 | 0.041 |
Age | 1.00 | 0.720 |
BMI1 | 0.99 | 0.209 |
Heavy alcohol use | 0.51 | 0.059 |
GERD1 | 1.60 | 0.051 |
Transplant recipient | 5.81 | 0.009 |
Immunosuppressive medication use1 | 0.87 | 0.746 |
Proton pump inhibitor use | 1.66 | 0.030 |
Corticosteroid use | 2.05 | 0.007 |
Tylenol use | 1.57 | 0.092 |
Aspirin use | 1.45 | 0.115 |
- Citation: Kimchy AV, Ahmad AI, Tully L, Lester C, Sanghavi K, Jennings JJ. Prevalence and clinical risk factors for esophageal candidiasis in non-human immunodeficiency virus patients: A multicenter retrospective case-control study. World J Gastrointest Endosc 2023; 15(6): 480-490
- URL: https://www.wjgnet.com/1948-5190/full/v15/i6/480.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i6.480